within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01B_AntiarrhythmicsClassIAndIii.C01BD05_Ibutilide;

model Ibutilide
  extends Pharmacolibrary.Drugs.ATC.C.C01BD05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C01BD05</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ibutilide is a class III antiarrhythmic agent that acts by prolonging the cardiac action potential and is primarily used for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to normal sinus rhythm. It is approved for intravenous use in hospitals and acute care settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Tisdale, JE, et al., &amp; Kovacs, RJ (2008). Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction. <i>Pharmacotherapy</i> 28(12) 1461–1470. DOI:<a href=\"https://doi.org/10.1592/phco.28.12.1461\">10.1592/phco.28.12.1461</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19025427/\">https://pubmed.ncbi.nlm.nih.gov/19025427</a></p></li><li><p>Naccarelli, GV, et al., &amp; VanderLugt, J (1996). Electrophysiology and pharmacology of ibutilide. <i>The American journal of cardiology</i> 78(8A) 12–16. DOI:<a href=\"https://doi.org/10.1016/s0002-9149(96)00560-7\">10.1016/s0002-9149(96)00560-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8903270/\">https://pubmed.ncbi.nlm.nih.gov/8903270</a></p></li><li><p>Hsu, CY, &amp; Walters, RR (1996). Pharmacokinetics of ibutilide and its enantiomers in dogs. <i>Chirality</i> 8(1) 18–23. DOI:<a href=\"https://doi.org/10.1002/(SICI)1520-636X(1996)8:1&lt;18::AID-CHIR5&gt;3.0.CO;2-C\">10.1002/(SICI)1520-636X(1996)8:1&lt;18::AID-CHIR5&gt;3.0.CO;2-C</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8845277/\">https://pubmed.ncbi.nlm.nih.gov/8845277</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Ibutilide;
